Stock Trading Ideas

AMC Stock On Watch For Q1 Earnings: Estimates, What Analysts Expect, Will Box Office Recover?
Rivian Q1 Earnings Highlights: Revenue Beat, EPS Miss, Vehicle Guidance Reaffirmed
Warren Buffett's AI Concerns Vs. Portfolio Potential: Berkshire's 3 AI Plays
Rivian Q1 Earnings Highlights: Revenue Beat, EPS Miss, Vehicle Guidance Reaffirmed
Warren Buffett's AI Concerns Vs. Portfolio Potential: Berkshire's 3 AI Plays
Apple's Strategic Moves Impresses Analyst as Buffett Adjusts Stake
Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

Trading Ideas Recent News

$581M In Deals: Top States Draw Major Cannabis Investments Despite Market Downturn
In the latest report from Viridian Capital Advisors, investment trends in the U.S. cannabis industry show a marked decrease, despite significant capital inflows in leading states such as California, New York and Massachusetts.
S&P 500's Remarkable Recovery And Surge As Investors Buzz Over Future Prospects And Rise In Stock Performance
The S&P 500 experienced a 1% increase on Monday, fueled by potential interest rate cuts. S&P 500 companies anticipating a 5% earnings growth from the previous year.
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
On Holding To Gain From Pace Of Product Introductions & Margin Expansion In Q1: Analyst
On Holding receives an Outperform rating with a $37 price target from Telsey Advisory Group, banking on strong Q1 pace of product launches and margin growth.
Taking Advantage Of The Pullback In Crypto To Bet On A Couple Of Picks & Shovels Plays
Waiting For The Right Setup  In our Exits post over the weekend, I wrote about using Chartmill’s Setup Rating, a measure of technical consolidation, to time entries into post-earnings trades;
Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy
Johnson & Johnson unveils promising TARIS platform data for bladder cancer treatment, highlighting ease of administration and significant revenue potential.
Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales growth at 8%-10%, reaffirming adjusted EPS guidance of $5.00-$5.16. William Blair attributes the EPS beat to margin expansion driven by technology and value-added services.
Shopify Prepares To Report Q1 Earnings: Charts Indicate Bullish Reversal, Analysts Predict Downside
Shopify (SHOP) will report Q1 earnings on Wednesday. Technical indicators suggest a bullish trend, while analysts foresee a downside potential of -17.70%.
Government Surveillance Contractor Palantir's AI Tactics Under Microscope By Wall Street Analysts: Must 'Demonstrate' Growth To Justify Valuation
Palantir stock is trading lower Tuesday after the company reported Q1 results. Analysts size up the results and what's next.
4 Sector ETFs & Stocks Likely to Benefit Despite Soft Jobs Data
The U.S. economy added 175,000 jobs in April, well below Wall Street expectations of 240,000, strengthening bets that the Federal Reserve will be able to cut interest rates in the coming months. Health care and social assistance led the way with a gain of 87,000 jobs.
Expert Says Exploration Co.'s Gold Project Is Shaping Up
Source: Michael Ballanger 05/03/2024 Michael Ballanger of GGM Advisory Inc. shares his thoughts on Fitzroy Minerals Inc. after having a discussion with its chairman.
DLE Co. Announces Strategic Investment To Deploy Extraction Tech
Source: Streetwise Reports 05/03/2024
Q1/24 Production from JV Mine in Line
Source: Joe Reagor 04/30/2024 Cash flow from this Mexican operation should provide the next catalyst for this Canadian silver producer, noted a ROTH Capital Markets report.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers